Radiodermatitis Market to Reach $442 Million by 2025 - Analysis By Product, Distribution Channel & Segment - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Radiodermatitis Market, 2014 - 2025" report to their offering.

The global radiodermatitis market is expected to reach USD 442.1 million by 2025.

The global radiodermatitis market is expected to grow at an unprecedented rate owing to the growing prevalence of cancer patients undergoing radiation therapy. The demand for radiodermatitis treatment is also accentuated by unmet medical needs of consumers in emerging as well as developed regions. Increasing focus of government healthcare organizations for promoting awareness about available treatment products for radiodermatitisis predicted to present the market with high potential growth opportunities.

In addition, increasing R&D activities in the area of life sciences is presumed to be one of the significant factors contributing toward growth of this market. For instance, in December 2016, Mölnlycke Health Care AB entered into a licensing agreement with a Texas-based R&D company Rochal Industries. This agreement was carried out to reinforce its position as a prevention solutions firm. In addition, they have signed a joint agreement to enhance their R&D capabilities and commercialize new patented technological platforms.Other factors such as escalating number of product launches with respect to radiodermatitis treatment and increasing demand for these products are expected to boost the overall market growth.

Companies Mentioned

  • Stratpharma AG
  • Smith & Nephew
  • Molnlycke Health Care AB
  • Derma Sciences Inc.
  • ConvaTec Inc.
  • BMG Pharma S.R.L.
  • Acelity
  • 3M
  • Alliqua BioMedical

Key Topics Covered:

1 Research Methodology & Scope

2 Executive Summary

3 Radiodermatitis Market Variables, Trends & Scope

4 Radiodermatitis Market: Product Estimates & Trend Analysis

5 Radiodermatitis Market: Distribution Channel Estimates & Trend Analysis

6 Radiodermatitis Market: Regional Estimates & Trend Analysis, by Product & Distribution Channel

7 Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/research/gkpf4p/radiodermatitis

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Dermatological Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Dermatological Drugs